Oscar Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-39.39	-442.9	26.12	-270.59	-609.55	-571.43
Depreciation & Amortization	29.18	28.89	32.15	30.69	15.28	14.61
Stock-Based Compensation	78.65	87.65	109.82	159.68	112.33	86.3
Other Adjustments	-47.24	-37.79	-28.76	0.14	7.29	41.08
Change in Receivables	-329.85	-93.22	-127.18	-15.47	-90.25	-76.46
Changes in Accounts Payable	2,126	205.49	152.77	-29.18	57.81	98.62
Changes in Accrued Expenses	268.47	98.66	390.74	28.26	424.15	201.67
Changes in Unearned Revenue	101.11	91.81	8.47	-13.08	3.95	3.14
Changes in Other Operating Activities	502.96	1,156	414.06	-162.62	459.34	20.73
Operating Cash Flow	2,835	1,095	978.19	-272.16	380.35	-181.75
Operating Cash Flow Growth	131.95%	11.93%	-	-	-	-
Capital Expenditures	-36.14	-36.37	-27.9	-25.58	-29.01	-25.89
Purchases of Investments	-1,592	-1,014	-2,134	-836.98	-1,193	-1,810
Proceeds from Sale of Investments	967.53	804.96	770.04	1,442	994.08	1,055
Other Investing Activities	3.42	4.28	3.93	-2.28	1.12	6.68
Investing Cash Flow	-657.09	-241.06	-1,387	577.19	-226.52	-774.52
Long-Term Debt Issued	-	410	-	-	305	-
Long-Term Debt Repaid	-	-	-	-	-	-153.17
Net Long-Term Debt Issued (Repaid)	-	410	-	-	305	-153.17
Issuance of Common Stock	50.44	55.03	68.39	3.96	1.3	1,407
Repurchase of Common Stock	-3.18	-4.04	-	-	-	-
Net Common Stock Issued (Repurchased)	47.26	51	68.39	3.96	1.3	1,407
Other Financing Activities	-	-61.79	-	2.49	-5.19	-15.21
Financing Cash Flow	390.74	399.21	68.39	6.45	301.11	1,239
Net Cash Flow	2,569	1,253	-340.85	311.47	454.94	282.45
Free Cash Flow	2,799	1,058	950.3	-297.74	351.34	-207.63
Free Cash Flow Growth	164.45%	11.38%	-	-	-	-
FCF Margin	21.04%	9.05%	10.35%	-5.08%	8.86%	-11.29%
Free Cash Flow Per Share	9.93	4.03	3.57	-1.34	1.65	-1.16
Levered Free Cash Flow	2,952	1,512	995.72	-442.23	630.25	-412.91
Unlevered Free Cash Flow	3,007	1,143	1,015	-410.02	342.16	-232.42

SEC Filings: 10-K · 10-Q